Literature DB >> 17082644

Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells.

Irma Lemaire1, Simonetta Falzoni, Natacha Leduc, Bin Zhang, Patrizia Pellegatti, Elena Adinolfi, Paola Chiozzi, Francesco Di Virgilio.   

Abstract

Multinucleated giant cells (MGC), a hallmark of chronic inflammatory reactions, remain an enigma of cell biology. There is evidence implicating the purinergic P2X7 receptor in the fusion process leading to MGC. To investigate this, we used HEK 293 cells stably transfected with either 1) the full-length rat P2X7 receptor (P2X7 cells), 2) a rat P2X7 receptor lacking the C-terminal domain (P2X7TC), or 3) a mock vector, and rat alveolar macrophages (MA) expressing the native receptor. P2X7 cells cultured in serum-free medium formed increased numbers of MGC and displayed a higher fusion index compared with mock transfectants. Stimulation of P2X7 pore-forming activity in P2X7 cells by polymyxin B (PMB) further increased significantly the formation of MGC. Conversely, blockers of P2X-receptors including oxidized ATP, brilliant blue G, and pyridoxal phosphate-6-azophenyl-2'-4'-disulfonic acid inhibited significantly MGC formation in both unstimulated and PMB-stimulated P2X7-transfected cells. In contrast, cells transfected with the truncated P2X7TC were devoid of pore-forming activity, did not respond to PMB stimulation, and failed to form enhanced numbers of MGC, thus behaving as mock transfectants. As found for P2X7-transfected cells, PMB also potentiated dose-dependently the formation of multinucleated MA by rat alveolar MA. Pretreatment with oxidized ATP abrogated the PMB stimulatory effects. Together, these data demonstrate unequivocally the participation of P2X7 receptor in the process of MGC formation. Our study also provides evidence suggesting that stimulation of the P2X7 receptor pathway in MA may mediate increased formation of MGC during chronic inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082644     DOI: 10.4049/jimmunol.177.10.7257

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

Review 2.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

3.  Lysophosphatidic acid stimulates osteoclast fusion through OC-STAMP and P2X7 receptor signaling.

Authors:  Young Sun Hwang; Gwang-Taek Ma; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Bone Miner Metab       Date:  2013-04-27       Impact factor: 2.626

Review 4.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

5.  P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways.

Authors:  Yan Qu; George R Dubyak
Journal:  Purinergic Signal       Date:  2009-02-03       Impact factor: 3.765

Review 6.  Giant cell formation and function.

Authors:  William G Brodbeck; James M Anderson
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

7.  The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells.

Authors:  Monica L Gavala; Zachary A Pfeiffer; Paul J Bertics
Journal:  J Leukoc Biol       Date:  2008-07-14       Impact factor: 4.962

8.  ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis.

Authors:  Ozlem Yilmaz; Luyu Yao; Kazuhiko Maeda; Timothy M Rose; Emma L Lewis; Memed Duman; Richard J Lamont; David M Ojcius
Journal:  Cell Microbiol       Date:  2007-11-13       Impact factor: 3.715

9.  Expression, signaling, and function of P2X7 receptors in bone.

Authors:  Matthew W Grol; Nattapon Panupinthu; Jasminka Korcok; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2009-02-18       Impact factor: 3.765

10.  Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control.

Authors:  Loren C Denlinger; Lei Shi; Arturo Guadarrama; Kathy Schell; Dawn Green; Alison Morrin; Kirk Hogan; Ronald L Sorkness; William W Busse; James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2008-11-21       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.